Abstract:Abstract Background Pneumonia is the third leading cause of mortality in Korea (2021). This can be attributed to the country’s rapid economic growth paired with demographic shift leading to a brisk increase in the aging population. Owing to this, we aimed to examine the regional disparity in pneumonia mortality and the associated determinants Methods Municipality-level pneumonia (ICD-10 code, J12-J18) deaths rates (2019) in Korea were extracted from Statistics Korea. Global Moran’s I statistics was used to test for spatial autocorrelation using 999 Monte Carlo simulations. Local Indicators of Spatial Association (LISA) clustering was used to explore the clusters of pneumonia mortality. The determinants were extracted from the Korean Statistical Information Service, including high-risk drinking, smoking rate, regular exercise rate, the prevalence of chronic diseases like hypertension, diabetes, and obesity, the number of doctors per 1000 population, passive smoking from households and workplaces, PM10 level, rate of unmet medical facilities, and the degree of financial independence. Following the selection of potential determinants through non-spatial generalized linear models, a Bayesian spatial regression using the Integrated Nested Laplace Approximation (INLA) was conducted to estimate the regional determinants of pneumonia mortality. The Besag, York, and Mollié (BYM) model was implemented. Results A positive spatial autocorrelation was present for pneumonia mortality (I = 0.446, P = 0.001). Regional disparity in pneumonia mortality was evident from LISA clustering, which revealed high-risk clusters in the northeast and central regions of the peninsula (Figure 1). Financial independence was protective (Relative risk (RR) = 0.848, 95% credible interval (CrI) = 0.774–0.928) whereas the prevalence of hypertension was a significant risk factor for pneumonia mortality (RR = 1.116, 95% CrI = 1.029-1.209). Root Mean Square Error (RMSE) in the prediction of pneumonia mortality by the BYM model was minimum (Figure 2-3).Figure 1.Local Indicators of Spatial Association (LISA) clustering of pneumonia mortality in Korea (2019).Figure 2.Spatial distribution of the observed pneumonia mortality versus that predicted by INLA-BYM. INLA-BYM, Integrated Nested Laplace Approximation-Besag York Mollié modelFigure 3.Spatial distribution of the predicted pneumonia mortality versus error in prediction. INLA-BYM, Integrated Nested Laplace Approximation-Besag York Mollié model; SE, Standard error Conclusion Regional disparity in pneumonia mortality exists in Korea, which can be explained by the degree of financial independence and the prevalence of hypertension. Policies to curb infection in high-risk areas are encouraged. Disclosures All Authors: No reported disclosures

Neighborhood-level disadvantages increase risk for invasive pneumococcal disease

Invasive Streptococcus Pneumoniae Infection among Hospitalized Patients in Jingzhou City, China, 2010-2012

Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002–2018: A Canadian Immunization Research Network (CIRN) study

Streptococcus pneumoniae Infection in Patients with Asplenia: A Spanish Perspective over a 25-Year Period

Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults

Early clinical predictors for the prognosis of invasive pneumococcal disease

Cardiovascular events after invasive pneumococcal disease: a retrospective cohort study

Clinical characteristics, antimicrobial resistance, and risk factors for mortality in paediatric invasive pneumococcal disease in Beijing, 2012–2017

Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital

Study of Pediatric Invasive Pneumococcal Disease in the 13-Pneumococcal Conjugated Vaccine Era

Neighborhood Socioeconomic Disadvantage Increases Risk of Severe Acute Respiratory Syndrome Coronavirus 2‐Mediated Otologic Dysfunction

Invasive Pneumococcal Disease in People With Human Immunodeficiency Virus in England, 1999-2017

Invasive pneumococcal disease in adults after the introduction of pneumococcal vaccination: a retrospective study in the metropolitan area of Zagreb, Croatia (2010–2022)

Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policies

1781. Spatial Epidemiology of Pneumonia Mortality in Korea: Regional Clustering and Bayesian Spatial Regression Analysis for its Determinants

Invasive pneumococcal diseases in Chinese children: a multicentre hospital-based active surveillance from 2019 to 2021

Incidence of Invasive and Noninvasive Pneumococcal Pneumonia Hospitalizations in People Aged ≥50 Years: Assessing Variability Across Denmark and Spain

1173. Risk of Pneumococcal Disease and Rate of Pneumococcal Vaccination Among Medicare Beneficiaries Aged 65 Years and Older Residing in Long-Term Care Facilities — United States, September 1, 2014 – December 31, 2019

Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021

Clinical and Microbial Determinants of Upper Respiratory Colonization with Streptococcus pneumoniae and Native Microbiota in People with HIV-1 and Control Adults

Clinical characteristics and serotype distribution of invasive pneumococcal disease in pediatric patients from Beijing, China